Browsing Tag
bioengineering
1 post
Humacyte’s $60mn funding boost sparks mixed investor reaction over equity dilution
Humacyte raises $60 million in an oversubscribed direct offering as investors debate dilution risks and long-term biotech value. Read the analysis.